Is 1-Month Dual Antiplatelet Therapy Applicable to Any Type of Drug-Eluting Stent in Any Clinical Scenario?
Y Minami - Circulation Journal, 2024 - jstage.jst.go.jp
Figure. Clinical trials regarding 1-month dual anti-platelet therapy (DAPT). The names of
clinical studies investigating the safety and feasibility of 1-month DAPT are listed.(◎), the …
clinical studies investigating the safety and feasibility of 1-month DAPT are listed.(◎), the …
[引用][C] Balancing Act―Prasugrel's Efficacy and Safety in Japanese Patients Undergoing Percutaneous Coronary Intervention―
Y Matsuoka, Y Sotomi, Y Sakata - Circulation Journal, 2024 - jstage.jst.go.jp
Prasugrel is a potent P2Y 12 receptor inhibitor and a first-line choice for acute coronary
syndrome (ACS) in Western countries. 1 Unlike clopidogrel, prasugrel is not affected by …
syndrome (ACS) in Western countries. 1 Unlike clopidogrel, prasugrel is not affected by …